Fax completed prior authorization request form to 800-854-7614 or submit Electronic Prior Authorization through
CoverMyMeds® or SureScripts.
All requested data must be provided. Incomplete forms or forms without the chart notes will be returned
Pharmacy Coverage Guidelines are available at
www.mercycareaz.org/providers/completecare-forproviders/pharmacy
Interferons
Pharmacy Prior Authorization Request Form
Do not copy for future use. Forms are updated frequently.
REQUIRED: Office notes, labs and medical testing relevant to request showing medical justification are required to support diagnosis
Member Name (first & last):
Prescribing Provider Information
Provider Name (first & last):
Dispensing Pharmacy Information
Requested Medication Information
Are there any contraindications to formulary medications?
If yes, please specify:
request
Continuation
of therapy
request
What medication(s) has member tried and failed for this diagnosis?
Medication request is NOT for an FDA- approved, or
compendia-supported diagnosis (circle one): Yes
Turn-Around Time for Review
Urgent – waiting 24 hours for a standard decision could seriously harm life, health,
or ability to regain maximum function, you can ask for an expedited decision.
Signature: _____________________________________________________
support the following:
Documentation ALT ≥2
times ULN
Documentation of elevated
Hepatitis B Virus DNA level
Above 2,000 IU/mL Hepatitis B e-
antigen negative
Significant histologic
disease
Above 20,000 IU/mL Hepatitis B
e-antigen positive
Is there evidence of compensated Liver disease?
Is lab report supportive of Hepatitis B e-antigen
POSITIVE?
Is lab report supportive of Hepatitis B e-
antigen NEGATIVE?
Follicular Non-Hodgkin’s Lymphoma (Stage III/IV)
Will requested medication be given in conjunction with anthracycline-containing combination chemotherapy?
Acquired Immune Deficiency Syndrome (AIDS)-Related Kaposi's Sarcoma
Confirm member age per above:
Confirm provider specialty per above:
Did member have less than a complete response to cladribine or pentostatin?
Effective: 8/18/2020 C6637-A, C6638-A, C11918-A 05-2020 Page 1 of 2
click to sign
signature
click to edit